The importance of vector control for the control and elimination of vector-borne diseases
- PMID: 31945061
- PMCID: PMC6964823
- DOI: 10.1371/journal.pntd.0007831
The importance of vector control for the control and elimination of vector-borne diseases
Abstract
Vector-borne diseases (VBDs) such as malaria, dengue, and leishmaniasis exert a huge burden of morbidity and mortality worldwide, particularly affecting the poorest of the poor. The principal method by which these diseases are controlled is through vector control, which has a long and distinguished history. Vector control, to a greater extent than drugs or vaccines, has been responsible for shrinking the map of many VBDs. Here, we describe the history of vector control programmes worldwide from the late 1800s to date. Pre 1940, vector control relied on a thorough understanding of vector ecology and epidemiology, and implementation of environmental management tailored to the ecology and behaviour of local vector species. This complex understanding was replaced by a simplified dependency on a handful of insecticide-based tools, particularly for malaria control, without an adequate understanding of entomology and epidemiology and without proper monitoring and evaluation. With the rising threat from insecticide-resistant vectors, global environmental change, and the need to incorporate more vector control interventions to eliminate these diseases, we advocate for continued investment in evidence-based vector control. There is a need to return to vector control approaches based on a thorough knowledge of the determinants of pathogen transmission, which utilise a range of insecticide and non-insecticide-based approaches in a locally tailored manner for more effective and sustainable vector control.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- World Health Organization. Global Vector Control Response 2017–2030 Geneva: WHO, 2017.
-
- World Health Organization. Global Technical Strategy for Malaria 2016–2030. Geneva: WHO, 2016.
-
- Hotez PJ. Forgotten People, Forgotten Diseases: The Neglected Tropical Diseases and their Impact on Global Health and Development. UK: ASM Press; 2013.
-
- Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. 10.1016/S0140-6736(15)60692-4 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- BB/R00532X/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- MR/M007383/1/MRC_/Medical Research Council/United Kingdom
- P01 AI098670/AI/NIAID NIH HHS/United States
- G0400031/MRC_/Medical Research Council/United Kingdom
- BB/L019035/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
